Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-25

Clinical Trial Update: Melatonin Postoperative Sleep Study in Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating melatonin as a postoperative sleep aid in breast cancer patients; the trial was terminated and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melatonin (melatonin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED | Results posted: 2011-01-25